Table 1.
Name | Included mutations | PAM (5’ to 3’) | Notes |
---|---|---|---|
SpCas9 | Native Streptococcus pyogenes Cas9 | NGG249 | 1368 amino acids |
VRER SpCas9 | D1135V, G1218R, R1335E, T1337R | NGCG17 | Altered PAM variant; Bacterial-selection-based screening |
VQR SpCas9 | D1135V, R1335Q, T1337R | NGAN or NGNG17 | Altered PAM variant; Bacterial-selection-based screening |
EQR SpCas9 | D1135E, R1335Q, T1337R | NGAG17 | Altered PAM variant; Bacterial-selection-based screening |
xCas9-3.7 | A262T, R324L, S409I, E480K, E543D, M694I, E1219V | NG, GAA, GAT18 | Altered PAM variant; Phage-assisted continuous evolution |
eSpCas9 (1.0) | K810A, K1003A, R1060A | NGG | Enhanced specificity; Structure-guided protein engineering19 |
eSpCas9 (1.1) | K810A, K1003A, R1060A | NGG | Enhanced specificity; Structure-guided protein engineering19 |
Cas9-HF1 | N497A, R661A, Q695A, Q926A | NGG | Enhanced specificity20 |
HypaCas9 | N692A, M694A, Q695A, H698A | NGG | Enhanced specificity21 |
evoCas9 | M495V, Y515N, K526E, R661Q | NGG | Enhanced specificity; yeast-based screening22 |
HiFi Cas9 | R691A | NGG | Enhanced specificity for ribonucleoprotein delivery23 |
ScCas9 | Native Streptococcus canis Cas9 | NNG250 | 1375 amino acids |
StCas9 | Native Streptococcus thermophilus Cas9 | NNAGAAW11,25 | 1121 amino acids |
NmCas9 | Native Neisseria meningitidis Cas9 | NNNNGATT26-28 | 1082 amino acids |
SaCas9 | Native Staphylococcus aureus Cas9 | NNGRRT29 | 1053 amino acids |
CjCas9 | Native Campylobacter jejuni Cas9 | NNNVRYM30 | 984 amino acids |
CasX | Deltaproteobacteria and Planctomycetes phyla | TTCN32 | 980 amino acids |
AAV, adeno-associated virus
ABA, abscisic acid
ABE, adenine base editor
ABI1, dimerizing ABA-binding protein
ADAR, adenosine deaminase acting on RNA
APEX2, engineered apurinic/apyrimidinic endodeoxyribonuclease 2 peroxidase
APOBEC1, apolipoprotein B mRNA editing enzyme complex-1
BE3, third generation base editor
BLESS, breaks labeling, enrichment on streptavidin and next-generation sequencing
Cas9-HF1, high fidelity Cas9 variant
CIB1, plant-derived cytochrome protein
CIRCLE-seq, circularization for in vitro reporting of cleavage effects by sequencing
CLOuD9, chromatin loop reorganization with CRISPR–dCas9
CORRECT, consecutive re-guide or re-Cas steps to erase CRISPR/Cas-blocked targets
CRISPR, clustered regularly interspaced short palindromic repeats
CRISPRa, CRISPR activation
CRISPRi, CRISPR interference
crRNA, CRISPR RNA
CRY2, plant-derived cytochrome protein
dCas9, catalytically deficient Cas9
Digenome-seq, in vitro Cas9-digested whole-genome sequencing
DNA, deoxyribonucleic acid
DNMT, DNA methyltransferase
DSB, double-strand break
dsDNA, double-stranded DNA
enAsCas12a, enhanced AsCas12a variant
enCHIP, engineered DNA-binding molecule-mediated chromatin immunoprecipitation
EQR, Cas9 variant with triple mutations
eSpCas9, enhanced specificity SpCas9 variant
evoCas9, evolved high fidelity Cas9 variant
FKBP, rapamycin-binding domain
FRB, rapamycin-binding domain
GFP, green fluorescent protein
gRNA, guide RNA
GUIDE-seq, genome-wide, unbiased identification of DSBs enabled by sequencing
HCV, hepatitis C virus
HDR, homologous-directed repair
HEPN, higher eukaryotes and prokaryotes nucleotide binding domain
HiFi Cas9, high fidelity Cas9 variant
HITI, homology-independent targeted integration
HNH, Cas9 nuclease domain
HTGTS, high-throughput, genome-wide, translocation sequencing
HypaCas9, hyper-accurate Cas9 variant
Indels, insertions or deletions
iPSC, induced pluripotent stem cell
lncRNA, long non-coding RNA
KRAB, Krϋppel-associated box
LNP, lipid Nanoparticle
MEMOIR, mutagenesis with optical in situ readout
mRNA, messenger RNA
nCas9, Cas9 nickase
NHEJ, non-homologous end joining
p65, NF-κB transactivating subunit
PAM, protospacer adjacent motif
PAMmer, PAM-presenting oligonucleotide
PFS, protospacer flanking sequence
PYL1, dimerizing ABA-binding protein
REPAIR, RNA editing for programmable A to I replacement
RNA, ribonucleic acid
RNAi, RNA interference
RNP, ribonucleoprotein
RuvC, Cas9 nuclease domain
SHERLOCK, specific high sensitivity enzymatic reporter unlocking
smFISH, single-molecule RNA fluorescence hybridization
ssDNA, single-stranded DNA
ssODN, single-stranded oligodeoxynucleotide
stgRNA, self-targeting gRNA
TET1, ten-eleven translocation methylcytosine dioxygenase 1
tracrRNA, trans-activating crRNA
tRNA, transfer RNA
UGI, uracil glycosylase inhibitor
VIVO, verification of in vivo off-targets
VP64, four repeats of the herpes simplex VP16 activation domain
VQR, Cas9 variant with triple mutations
VRER, Cas9 variant with quadruple mutations
xCas9, expanded PAM SpCas9 variant
AsCas12a – Acidaminococcus spp. Cas12a
CjCas9 – Campylobacter jejuni Cas9
FnCas9 – Francisella novicida Cas9
LbCas12a – Lachnospiraceae spp. Cas12a
LwaCas13a – Leptotrichia wadei Cas13a
NmCas9 – Neisseria meningitidis Cas9
PaCsy4 – Pseudomonas aeruginosa Csy4
PspCas13b – Prevotella sp. P5-125 Cas13b
SaCas9 – Staphylococcus aureus Cas9
ScCas9 – Streptococcus canis Cas9
SpCas9 – Streptococcus pyogenes Cas9
StCas9 – Streptococcus thermophilus Cas9